SMS Pharmaceuticals Ltd
NSE:SMSPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SMS Pharmaceuticals Ltd
NSE:SMSPHARMA
|
IN |
|
P
|
Pelayaran Nasional Ekalya Purnamasari Tbk PT
IDX:ELPI
|
ID |
|
Furniweb Holdings Ltd
HKEX:8480
|
MY |
|
C
|
Cosco Capital Inc
XPHS:COSCO
|
PH |
|
China Development Bank Financial Leasing Co Ltd
HKEX:1606
|
CN |
|
F
|
Fastenal Co
XETRA:FAS
|
US |
|
Genesys International Corporation Ltd
NSE:GENESYS
|
IN |
|
Legrand SA
PAR:LR
|
FR |
|
Posco International Corp
KRX:047050
|
KR |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
US |
|
A
|
Action SA
WSE:ACT
|
PL |
|
B2Gold Corp
TSX:BTO
|
CA |
|
Temenos AG
SIX:TEMN
|
CH |
|
C
|
China Hongguang Holdings Ltd
HKEX:8646
|
CN |
|
C
|
China Chippacking Technology Co Ltd
SSE:688216
|
CN |
|
Z
|
Zeder Investments Ltd
JSE:ZED
|
ZA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SMSPHARMA's stock price target?
Not Available
SMSPHARMA doesn't have any price targets made by Wall Street professionals.
What is SMS Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
-1%
For the last 13 years the
compound annual growth rate for
SMS Pharmaceuticals Ltd's revenue is
10%.
The projected
CAGR
for the next 8 years is
-1%.
What is SMS Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
SMS Pharmaceuticals Ltd's operating income is
12%.
The projected
CAGR
for the next 8 years is
1%.
What is SMS Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
-3%
For the last 13 years the
compound annual growth rate for
SMS Pharmaceuticals Ltd's net income is
37%.
The projected
CAGR
for the next 8 years is
-3%.
